Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition

Melina Beykou; Mar Arias-Garcia; Theodoros I. Roumeliotis; Jyoti S. Choudhary; Nicolas Moser; Pantelis Georgiou; Chris Bakal

doi:10.1038/s41597-022-01512-1

Scientific Data (Jul 2022)

Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition

Melina Beykou,
Mar Arias-Garcia,
Theodoros I. Roumeliotis,
Jyoti S. Choudhary,
Nicolas Moser,
Pantelis Georgiou,
Chris Bakal

Affiliations

Melina Beykou: Imperial College London, Department of Electrical and Electronic Engineering, Circuits and Systems Group, South Kensington Campus
Mar Arias-Garcia: Institute of Cancer Research, Division of Cancer Biology, Dynamical Cell Systems
Theodoros I. Roumeliotis: Institute of Cancer Research, Division of Cancer Biology, Functional Proteomics
Jyoti S. Choudhary: Institute of Cancer Research, Division of Cancer Biology, Functional Proteomics
Nicolas Moser: Imperial College London, Department of Electrical and Electronic Engineering, Circuits and Systems Group, South Kensington Campus
Pantelis Georgiou: Imperial College London, Department of Electrical and Electronic Engineering, Circuits and Systems Group, South Kensington Campus
Chris Bakal: Institute of Cancer Research, Division of Cancer Biology, Dynamical Cell Systems

DOI: https://doi.org/10.1038/s41597-022-01512-1
Journal volume & issue: Vol. 9, no. 1
pp. 1 – 13

Abstract

Read online

Measurement(s) Proteomic Profiling Technology Type(s) Liquid Chromatography Mass Spectrometry Factor Type(s) Palbociclib dosage Sample Characteristic - Organism Homo sapiens Sample Characteristic - Environment cell culture

Published in Scientific Data

ISSN: 2052-4463 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/sdata/

About the journal